Test Price
3,000 AED✅ Home Collection Available
Fungal Genome De Novo Assembly and Annotation (Illumina) in UAE | 3,000 AED | DHA Licensed
Executive Summary & Core Metrics
Comprehensive fungal genomic profiling delivering 99.9% diagnostic sensitivity through full-genome reconstruction. This Illumina NGS-based test identifies species, virulence factors, and antifungal resistance genes in a single analysis, supporting targeted therapy for recurrent or resistant infections.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Fungal Genome De Novo Assembly and Annotation (Illumina) delivers high-resolution genomic data from a standard whole blood sample or purified fungal culture. The laboratory employs Illumina paired-end sequencing followed by de novo assembly using SPAdes, and functional annotation via BLAST and antiSMASH databases. This approach provides a complete molecular fingerprint of the pathogen, including resistance mutations (e.g., ERG11, FKS1) and virulence determinants, enabling precise therapeutic selection.
| Feature | Our Test (Illumina NGS) | Closest Alternative (Culture + MALDI‑TOF) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity & Species Resolution | 80–90% typical; often fails with cryptic species |
| Methodology | Illumina NGS + De Novo Assembly (SPAdes) + BLAST/antiSMASH Annotation | Phenotypic growth & protein mass spectrometry |
| Resistance & Virulence Detection | Full gene‑by‑gene scan (ERG11, FKS1, etc.) | Limited by phenotypic susceptibility testing |
| Turnaround Time | 4 weeks (genome‑grade result) | 2–5 days (genus‑level ID only) |
| Suitable for | Recurrent, invasive, or antifungal‑resistant infections; research | Routine clinical mycology |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I understand the clinical complexity of persistent fungal infections. This genomic test provides the definitive molecular characterisation needed to guide targeted antifungal therapy. Results must always be interpreted in conjunction with the full clinical picture and conventional microbiological findings.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Do not discontinue prescribed antifungal medication without consulting your doctor.
This test is a diagnostic tool; it does not replace ongoing treatment. Any change in medication must be made by your treating physician.
Exclusion Criteria & Emergency Red Flags
- Uncontrolled bleeding or inability to provide a safe blood sample.
- Test is not intended for acute, life‑threatening fungal sepsis; standard emergency diagnostics must be used first.
- If you develop high fever, shortness of breath, or severe deterioration, seek immediate emergency care.
- Prior antifungal treatment may affect culture viability; discuss with your physician before sample collection.
Patient FAQ & Clinical Guidance
1. What exactly does Fungal Genome De Novo Assembly and Annotation tell my doctor?
This genomic test reconstructs the entire fungal DNA sequence, revealing the exact species, resistance mutations, and virulence genes in one report. It is especially valuable when standard tests cannot identify the fungus or when infection persists despite treatment.
2. When would my dermatologist or infectious disease specialist recommend this test?
Your specialist orders this for recurrent, deep, or antifungal‑resistant fungal infections where conventional culture and sensitivity fail to guide therapy. It is also used for epidemiological typing and clinical research.
3. Are there any special preparations or risks I should know about?
No fasting or special preparation is required; simply inform your doctor about all antifungal medications you are taking, as they may influence culture growth. The blood draw is a standard venipuncture with minimal discomfort; our mobile phlebotomist follows strict cold‑chain protocols under ISO 9001:2015 certification.
4. How is my genomic data protected?
All genomic data is encrypted and handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields. Your results are confidential and only shared with your treating physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with all applicable UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensures your genomic data is processed lawfully, with explicit consent and full encryption.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governs the secure handling of electronic health records and digital diagnostic data.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguards patient safety and consent during sample collection and clinical testing.
All laboratory operations are ISO 9001:2015 certified (Cert. INT/EGQ/2509DA/3139), and home collection services are performed by trained phlebotomists under strict chain-of-custody protocols.
Clinical & Logistical Metadata
| Test Name | Fungal Genome De Novo Assembly and Annotation (Illumina) |
| Price (AED) | 3,000 |
| Turnaround Time | 4 weeks (28 calendar days) |
| Sample Type / Matrix | Whole blood (EDTA) or purified fungal culture; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available |
| Methodology Used | Illumina paired-end sequencing, de novo assembly (SPAdes), BLAST/antiSMASH annotation |
| ICD-10-CM Code | B49 (Unspecified mycosis) – Additional specific codes may apply based on clinical presentation. |
| LOINC Code | 82147-2 (Fungal DNA sequence determination in Specimen by Sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians